LMEDD (LataMed AI) ROCE %: -5.28% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LMEDD LataMed AI Corp LMEDD
26 GF Score
Price $1.23
! 3 Warning Signs
View Full Analysis

What is LataMed AI ROCE %?

LataMed AI LMEDD +13.78% 26 ROCE % is -5.28% as of Mar. 2026. GuruFocus rates LMEDD with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. LataMed AI's annualized ROCE % for the quarter that ended in Mar. 2026 was -5.28%.

LataMed AI  (OTCPK:LMEDD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

LataMed AI ROCE % Related Terms

LataMed AI ROCE % Historical Data

* Premium members only.

The historical data trend for LataMed AI's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LataMed AI ROCE % Chart

LataMed AI Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
0.00 0.00 0.00

LataMed AI Quarterly Data
Sep09 Sep10 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -5.28
LMEDD
26GF Score
LataMed AI Corp LMEDD
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LataMed AI ROCE % Calculation

LataMed AI's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-0.172/( ( (0 - 0.574) + (0 - 0.631) )/ 2 )
=-0.172/( (-0.574+-0.631)/ 2 )
=-0.172/-0.6025
=28.55 %

LataMed AI's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-0.172/( ( (0 - 0.631) + (7.824 - 0.684) )/ 2 )
=-0.172/( ( -0.631 + 7.14 )/ 2 )
=-0.172/3.2545
=-5.28 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -5.28% mean?
LataMed AI (LMEDD) has a ROCE % of -5.28% as of Mar. 2026.
Is LataMed AI's ROCE % too high?
LataMed AI's current ROCE % is -5.28%. Overall, LataMed AI has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does LataMed AI's ROCE % compare to KLTR and BZAI?
LataMed AI's ROCE % of -5.28% can be compared against companies in the Software industry. The industry median ROCE % is 5.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Software company?
The median ROCE % among Software companies is 5.29, based on 2,719 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Software industry, the median ROCE % is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LataMed AI's current ROCE % is -5.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LataMed AI stock overvalued right now?
LataMed AI (LMEDD) has a current ROCE % of -5.28%. The current ROCE % is -5.28%. LataMed AI's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For LataMed AI (LMEDD), the current ROCE % is -5.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LataMed AI Business Description

Address Av. Romulo Gallegos con Av. Las Palmas, Edif. Torre Gerencial Los Andes, Caracas, VEN, 1071
LataMed AI Corp is a technology company focused on the development and deployment of artificial intelligence-driven healthcare solutions across Latin America. Its healthcare platform includes AI-enabled analytics, telehealth infrastructure, and coordinated care systems designed to support healthcare delivery in emerging markets. The company develops digital infrastructure for patient prioritization, clinical workflow management, telehealth access, care coordination, and healthcare system operations. It holds issued patents for its core AI modules-CardioAI, PulmoAI, and NeuroAI-which deliver predictive analytics for cardiovascular, pulmonary, and neurological disease detection and management.
26GF Score

Get the complete analysis for LMEDD

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.23
Price